ATE549014T1 - Prostaglandin-fettemulsion, verfahren zu ihrer herstellung, verfahren zu ihrer stabilisierung und emulgierendes mittel - Google Patents

Prostaglandin-fettemulsion, verfahren zu ihrer herstellung, verfahren zu ihrer stabilisierung und emulgierendes mittel

Info

Publication number
ATE549014T1
ATE549014T1 AT07806606T AT07806606T ATE549014T1 AT E549014 T1 ATE549014 T1 AT E549014T1 AT 07806606 T AT07806606 T AT 07806606T AT 07806606 T AT07806606 T AT 07806606T AT E549014 T1 ATE549014 T1 AT E549014T1
Authority
AT
Austria
Prior art keywords
fat emulsion
stabilizing
producing
emulsifying agent
prostaglandin
Prior art date
Application number
AT07806606T
Other languages
English (en)
Inventor
Satomi Kamiya
Tomonori Uchida
Hideto Yoshida
Yasutaka Inoue
Noboru Yamada
Kenichi Kajihara
Original Assignee
Q P Corp
Towa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39157190&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE549014(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Q P Corp, Towa Pharmaceutical Co Ltd filed Critical Q P Corp
Application granted granted Critical
Publication of ATE549014T1 publication Critical patent/ATE549014T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT07806606T 2006-09-05 2007-09-03 Prostaglandin-fettemulsion, verfahren zu ihrer herstellung, verfahren zu ihrer stabilisierung und emulgierendes mittel ATE549014T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006240572 2006-09-05
PCT/JP2007/067133 WO2008029763A1 (en) 2006-09-05 2007-09-03 Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent

Publications (1)

Publication Number Publication Date
ATE549014T1 true ATE549014T1 (de) 2012-03-15

Family

ID=39157190

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07806606T ATE549014T1 (de) 2006-09-05 2007-09-03 Prostaglandin-fettemulsion, verfahren zu ihrer herstellung, verfahren zu ihrer stabilisierung und emulgierendes mittel

Country Status (9)

Country Link
US (1) US8334321B2 (de)
EP (1) EP2065043B1 (de)
JP (1) JP5193870B2 (de)
KR (1) KR101411758B1 (de)
CN (1) CN101511367B (de)
AT (1) ATE549014T1 (de)
RU (1) RU2470644C2 (de)
TW (1) TWI403515B (de)
WO (1) WO2008029763A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5582635B2 (ja) * 2008-01-24 2014-09-03 テクノガード株式会社 プロスタグランジン含有脂肪乳剤およびその製造方法
EP3318255B1 (de) 2009-06-15 2021-03-10 Amarin Pharmaceuticals Ireland Limited Zusammensetzungen und verfahren zur behandlung des schlaganfalles bei patienten mit gleichzeitiger statin-therapie
BR112013025070A2 (pt) * 2011-03-31 2017-02-14 Fujifilm Corp emulsão graxa contendo prostaglandina
CN105012248B (zh) * 2014-04-29 2018-01-02 北京蓝丹医药科技有限公司 一种注射用前列地尔脂肪乳及其制备方法
CN105310976B (zh) * 2014-06-04 2018-08-21 北京蓝丹医药科技有限公司 一种稳定的前列地尔组合物
CN106389328B (zh) * 2015-07-31 2019-07-23 北京蓝丹医药科技有限公司 一种注射用前列地尔脂肪乳
CN107412160B (zh) * 2016-05-24 2021-03-23 四川科伦药物研究院有限公司 一种含前列腺素的脂肪乳剂及其制备方法
CN108653208A (zh) * 2017-03-30 2018-10-16 北京蓝丹医药科技有限公司 一种前列地尔注射液
LT3750536T (lt) 2018-09-24 2026-03-25 Amarin Pharmaceuticals Ireland Limited Širdies ir kraujagyslių sistemos reiškinių rizikos subjekto organizme sumažinimo būdai
BR112022009189A2 (pt) 2019-11-12 2022-07-26 Amarin Pharmaceuticals Ie Ltd Métodos para reduzir o risco de eventos cardiovasculares em um sujeito com fibrilação atrial e/ou palpitação atrial
CN110934829B (zh) * 2019-12-30 2021-10-01 辅必成（上海）医药科技有限公司 一种阿瑞吡坦的纳米胶束
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure
KR20240142470A (ko) * 2022-01-26 2024-09-30 애머린 파마슈티칼스 아일랜드 리미티드 지방산의 림프 방출 조성물 및 림프 혼입과 전신 질환 치료를 위한 이의 용도

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
JPS58222014A (ja) 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
JPS59216820A (ja) 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
WO1988009170A1 (en) * 1987-05-22 1988-12-01 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
JP2602964B2 (ja) 1989-10-16 1997-04-23 裕 水島 プロスタグランジン類縁体およびその脂肪乳剤
US5194670A (en) 1989-10-16 1993-03-16 Yutaka Mizushima, Asahi Glass Company Ltd. Emulsion of lipid containing a prostaglandin analogue
JPH04356417A (ja) 1990-09-26 1992-12-10 Kao Corp 静脈注射用脂肪乳剤
WO1992004886A1 (fr) 1990-09-26 1992-04-02 Meito Sangyo Co., Ltd. Emulsion grasse pour injection intraveineuse
JPH04338333A (ja) * 1991-05-13 1992-11-25 Asahi Chem Ind Co Ltd プロスタグランジンｅ１脂肪乳剤
JPH05139977A (ja) 1991-05-17 1993-06-08 Green Cross Corp:The プロスタグランジン類リポソーム複合体を充填した注射器
JPH0769878A (ja) 1993-06-28 1995-03-14 Otsuka Pharmaceut Factory Inc アミノ酸加脂肪乳剤
GB9501286D0 (en) * 1995-01-24 1995-03-15 Ciba Geigy Ag Pharmaceutical compositions and preparations thereof
US6214375B1 (en) 1996-07-16 2001-04-10 Generex Pharmaceuticals, Inc. Phospholipid formulations
JP2003501376A (ja) * 1999-06-04 2003-01-14 スカイファーマ インコーポレーテッド 疎水性薬物の持続性放出のための油コア組成物
JP4421699B2 (ja) 1999-06-30 2010-02-24 大洋薬品工業株式会社 静脈注射可能なプロスタグランジン脂肪乳剤
EP1420783A4 (de) 2001-08-03 2009-09-30 Takeda Pharmaceutical Stabile emulsionszusammensetzung
US20040105778A1 (en) 2002-10-04 2004-06-03 Elan Pharma International Limited Gamma irradiation of solid nanoparticulate active agents
AU2003289163A1 (en) 2002-12-06 2004-06-30 Otsuka Pharmaceutical Factory, Inc. Propofol-containing fat emulsions

Also Published As

Publication number Publication date
WO2008029763A1 (en) 2008-03-13
TWI403515B (zh) 2013-08-01
JPWO2008029763A1 (ja) 2010-01-21
CN101511367B (zh) 2011-08-17
US20100112066A1 (en) 2010-05-06
EP2065043A1 (de) 2009-06-03
RU2009112547A (ru) 2010-10-20
RU2470644C2 (ru) 2012-12-27
CN101511367A (zh) 2009-08-19
US8334321B2 (en) 2012-12-18
KR101411758B1 (ko) 2014-06-25
JP5193870B2 (ja) 2013-05-08
KR20090064526A (ko) 2009-06-19
EP2065043A4 (de) 2011-07-06
TW200817423A (en) 2008-04-16
EP2065043B1 (de) 2012-03-14

Similar Documents

Publication Publication Date Title
ATE549014T1 (de) Prostaglandin-fettemulsion, verfahren zu ihrer herstellung, verfahren zu ihrer stabilisierung und emulgierendes mittel
EP2055314A4 (de) Aktivator mit einem biotensid als wirkstoff, mannosylerythritol-lipid und herstellungsverfahren dafür
ATE509692T1 (de) Verfahren zur herstellung einer öl und strukturierungsmittel enthaltenden essbaren dispersion
WO2008081934A1 (ja) 乳由来リン脂質を含有する乳幼児脳発達促進剤及びそれを含有する食品組成物
GB2459809A (en) Fatty acid formulations and methods of use thereof
ATE503460T1 (de) Selbstmikroemulgierende arzneiabgabesysteme
WO2006071796A3 (en) Pulmonary surfactant formulations
DK2436275T3 (da) Lipidsammensætning til forbedring af hjernefunktion
ZA200408953B (en) Method and dietary composition for improving lipid digestibility
CY1112981T1 (el) Μεθοδος και συνθεση για την αγωγη της ρινιτιδας
CY1114681T1 (el) Παραγωγο εστερα του αμινοφωσφορικου οξεος και τροποποιητης του υποδοχεα της 1-φωσφορικης σφιγγοσινης που το περιεχει ως δραστικο συστατικο
NZ610465A (en) Clevidipine emulsion formulations containing antimicrobial agents
WO2008087348A3 (fr) Emulsion comprenant au moins un retinoide et du péroxyde de benzoyle
BRPI0907480A2 (pt) emulsões de óleo em água estabilizadas incluindo ingredientes agricolamente ativos
NO20080526L (no) Emulgeringssystem, emulsjon og anvendelse derav
NZ591289A (en) A whipping agent
DK1761132T3 (da) Tyggegummi, som omfatter aromastofemulsion
ZA200904461B (en) Non-specific immunostimulating agents
MX2009012782A (es) Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados.
NO20092131L (no) Fettsyrealkoholer
AR047796A1 (es) Composiciones cosmeticas que exhiben propiedades humectantes duraderas
CH700328B8 (de) O/W-Emulsion zur Pflege der Hand.
PL1673065T3 (pl) Mikroemulsje retinoidów i zawierające je kompozycje farmaceutyczne
WO2008013669A3 (en) Alpha hydroxy acid sustained release formulation
ATE446685T1 (de) Öl-in-wasser-emulsion, die coenzym q10 enthält, und verfahren zu ihrer herstellung